Journal article
Advancing complement inhibition for the treatment of malarial anemia: a translational roadmap
Malaria journal
08/25/2026
DOI: 10.1186/s12936-026-06120-7
Abstract
Severe anemia is responsible for hundreds of thousands of deaths in children with malaria. For every Plasmodium-infected erythrocyte that is lysed, considerably more than 10 uninfected erythrocytes are cleared by extravascular hemolysis, thus leading to anemia. Compelling evidence indicates that breakdown products released from infected erythrocytes in the bloodstream activate complement and promote “innocent bystander” deposition of C3 activation fragments on the uninfected erythrocytes, thereby sensitizing them for elimination. We propose a series of in vitro experiments with blood cultures of malaria parasites to test the hypothesis that use of inhibitors that block complement at the C3 activation step can preserve and protect uninfected erythrocytes from C3 deposition. Successful demonstration of in vitro protection will set the stage for clinical trials based on the limited and focused use of complement inhibitors to prevent severe anemia in malaria.
Details
- Title: Subtitle
- Advancing complement inhibition for the treatment of malarial anemia: a translational roadmap
- Creators
- Ronald P. Taylor - University of VirginiaD. Gray Heppner - ClearMotion (United States)John D. Lambris - University of PennsylvaniaMargaret A. Lindorfer - University of VirginiaDimitrios C. Mastellos - National Centre of Scientific Research "Demokritos"Rosario Notaro - Istituto per lo Studio e la Prevenzione OncologicaAlexander V. Pichugin - Walter Reed Army Institute of ResearchAntonio M. Risitano - Azienda Ospedaliera S.Giuseppe MoscatiChristoph Q. Schmidt - Universität UlmRichard J. H. Smith - University of IowaJosé A. Stoute - Jackson Memorial HospitalJohn N. Waitumbi - United States Army Medical Research Directorate - AfricaYuzhou Zhang - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Malaria journal
- DOI
- 10.1186/s12936-026-06120-7
- ISSN
- 1475-2875
- eISSN
- 1475-2875
- Publisher
- Springer Nature
- Language
- English
- Electronic publication date
- 08/25/2026
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Molecular Physiology and Biophysics; Anatomy and Cell Biology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Otolaryngology; Internal Medicine
- Record Identifier
- 9985220286602771
Metrics
1 Record Views